Anti-Reflux Surgery Promising in Idiopathic Pulmonary Fibrosis
In phase 2 study, surgery for abnormal acid GER in IPF patients was safe, well-tolerated
September 2018 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for September 2018. This roundup includes the latest...
September 2018 Briefing – Pain Management
Here are what the editors at HealthDay consider to be the most important developments in Pain Management for September 2018. This roundup includes the...
September 2018 Briefing – Geriatrics
Here are what the editors at HealthDay consider to be the most important developments in Geriatrics for September 2018. This roundup includes the latest...
September 2018 Briefing – Cosmetic Surgery
Here are what the editors at HealthDay consider to be the most important developments in Cosmetic Surgery for September 2018. This roundup includes the...
September 2018 Briefing – Anesthesiology
Here are what the editors at HealthDay consider to be the most important developments in Anesthesiology for September 2018. This roundup includes the latest...
September 2018 Briefing – Radiology
Here are what the editors at HealthDay consider to be the most important developments in Radiology for September 2018. This roundup includes the latest...
September 2018 Briefing – Pathology
Here are what the editors at HealthDay consider to be the most important developments in Pathology for September 2018. This roundup includes the latest...
September 2018 Briefing – Nephrology
Here are what the editors at HealthDay consider to be the most important developments in Nephrology for September 2018. This roundup includes the latest...
September 2018 Briefing – Otolaryngology
Here are what the editors at HealthDay consider to be the most important developments in Otolaryngology for September 2018. This roundup includes the latest...
